HAWAII MINORITY-BASED CCOP

描述(由申请人提供)： 夏威夷少数族裔社区临床肿瘤学计划(MBCCOP)的目标是在过去10年为夏威夷癌症患者和高危个人提供NCI临床试验的成功基础上，通过以下方式降低癌症发病率、发病率和死亡率： 1.为在多民族的夏威夷州扩大临床研究提供支持 少数民族癌症患者占多数的人群； 2.发挥现代科学治疗和癌症预防的优势 将研究控制在本社区的少数族裔个人； 3.增加初级保健提供者和其他专家的参与 癌症治疗、预防和控制研究； 4.促进未得到充分服务的人群更广泛地参与NCI批准的研究； 5.加强现有的业务基础，以扩大这一人群的癌症预防和控制研究。 夏威夷癌症研究中心将作为MBCCOP的行政总部，指导NCI批准的癌症治疗、预防和症状控制临床试验的招募、积累和数据管理。临床试验来源包括：SWOG、NCCTG、COG、GOG、RTOG、URCC、NSABP预防试验和CTSU。参与的医生包括瓦胡岛上的所有肿瘤学家，以及来自其他医学和非医学专业的专业人员。所有主要的瓦胡岛医院都将作为组成机构。MBCCOP将允许夏威夷人民-大约75%的少数民族-受益于获得最先进的癌症治疗、预防和症状控制干预措施，并提供关于独特人群的临床研究数据。

DESCRIPTION (provided by applicant): The objective of the Hawaii Minority-Based Community Clinical Oncology Program (MBCCOP) is to build on its past 10 years' success in providing NCI clinical trials to Hawaii cancer patients and high risk individuals in order to reduce cancer incidence, morbidity and mortality by: 1. Providing support to expand clinical research in the state of Hawaii, a multi-ethnic population with a majority of ethnic minority cancer patients; 2. Bringing the advantages of state-of-the-science treatment and cancer prevention and control research to minority individuals in their own communities; 3. Increasing the involvement of primary health care providers and other specialists in cancer treatment, prevention and control studies; 4. Facilitating wider participation among underserved populations in NCI-approved research; 5. Strengthening the operational base that currently exists to extend cancer prevention and control research in this population. The Cancer Research Center of Hawaii will serve as the administrative headquarters for the MBCCOP to direct recruitment, accrual, and data management for NCI-approved cancer treatment, prevention and symptom control clinical trials. Sources of clinical trials include: SWOG, NCCTG, COG, GOG, RTOG, URCC, NSABP prevention trials, and CTSU. Participating physicians include all oncologists on the island of Oahu, as well as professionals from other medical and non-medical specialties. All major Oahu hospitals will serve as component institutions. The MBCCOP will allow the people of Hawaii, about 75 percent who are ethnic minorities, to benefit from access to state-of-the science cancer treatment, prevention and symptom control interventions, and to provide clinical research data on a unique population.